Multiple behaviour change intervention and outcomes in recently diagnosed type 2 diabetes: the ADDITION-Plus randomised controlled trial
Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: AIMS/HYPOTHESIS: The aim of this study was to assess whether or not a theory-based behaviour change intervention delivered by trained and quality-assured lifestyle facilitators can achieve and maintain improvements in physical activity, dietary change, medication adherence and smoking cessation in people with recently diagnosed type 2 diabetes. METHODS: An explanatory randomised controlled trial was conducted in 34 general practices in Eastern England (Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care-Plus [ADDITION-Plus]). In all, 478 patients meeting eligibility criteria (age 40 to 69 years with recently diagnosed screen or clinically detected diabetes) were individually randomised to receive either intensive treatment (n = 239) or intensive treatment plus a theory-based behaviour change intervention led by a facilitator external to the general practice team (n = 239). Randomisation was central and independent using a partial minimisation procedure to balance stratifiers between treatment arms. Facilitators taught patients skills to facilitate change in and maintenance of key health behaviours, including goal setting, self-monitoring and building habits. Primary outcomes included physical activity energy expenditure (individually calibrated heart rate monitoring and movement sensing), change in objectively measured fruit and vegetable intake (plasma vitamin C), medication adherence (plasma drug levels) and smoking status (plasma cotinine levels) at 1 year. Measurements, data entry and laboratory analysis were conducted with staff unaware of participants' study group allocation. RESULTS: Of 475 participants still alive, 444 (93%; intervention group 95%, comparison group 92%) attended 1-year follow-up. There were no significant differences between groups in physical activity (difference: +1.50 kJ kg(-1) day(-1); 95% CI -1.74, 4.74), plasma vitamin C (difference: -3.84 μmol/l; 95% CI -8.07, 0.38), smoking (OR 1.37; 95% CI 0.77, 2.43) and plasma drug levels (difference in metformin levels: -119.5 μmol/l; 95% CI -335.0, 95.9). Cardiovascular risk factors and self-reported behaviour improved in both groups with no significant differences between groups. CONCLUSIONS/INTERPRETATION: For patients with recently diagnosed type 2 diabetes receiving intensive treatment in UK primary care, a facilitator-led individually tailored behaviour change intervention did not improve objectively measured health behaviours or cardiovascular risk factors over 1 year. TRIAL REGISTRATION: ISRCTN99175498 FUNDING: The trial is supported by the Medical Research Council, the Wellcome Trust, National Health Service R&D support funding (including the Primary Care Research and Diabetes Research Networks) and National Institute of Health Research under its Programme Grants for Applied Research scheme. The Primary Care Unit is supported by NIHR Research funds. Bio-Rad provided equipment for HbA1c testing during the screening phase.
Source: Diabetologia
Authors: on behalf of the ADDITION-Plus study team, Simon J. Griffin, Rebecca K. Simmons, A. Toby Prevost, Kate M. Williams, Wendy Hardeman, Stephen Sutton, Søren Brage, Ulf Ekelund, Richard A. Parker, Nicholas J. Wareham, Ann Louise Kinmonth
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, behaviour change interventions, physical activity, dietary change, fruit and vegetable intake, medication adherence, smoking cessation, intensive treatment, primary care, self-monitoring, goal setting, newly diagnosed diabetes, cardiovascular risk factors, metformin, heart rate monitoring, plasma vitamin C, plasma cotinine, plasma drug concentration
Open Access status: hybrid
Estimated APC paid: $3,490
Funders: Wellcome Trust, National Institute for Health and Care Research, Diabetes UK, University of Cambridge, University of Southampton, King's College London, Cardiff University, Cambridge University Hospitals, Bangor University, Medical Research Council, Menzies Centre for Australian Studies, King's College London, University of London, Programme Grants for Applied Research, Royal Holloway, University of London, NIHR School for Primary Care Research, NIHR Cambridge Biomedical Research Centre
Awards: Aetiology of type 2 diabetes and related metabolic disorders, G2289583185, Development and evaluation of very brief behaviour change interventions to reduce the risk of chronic disease in primary care, G2448080532, Epidemiological contribution to primary and secondary prevention of diabetes and obesity, NIHR Senior Investigator Award, G5512690733, G6514246486, A randomised trial of the cost-effectiveness of a program of screening and intensive multifactorial intervention for Type 2 diabetes in primary care., Reducing the burden of type 2 diabetes: translating epidemiology and behavioural science into preventive action, Physical activity epidemiology, NIHR Senior Investigator Award
OpenAlex ID: W2006714112
